clinical diagnostics
drug discovery
general lab
lab automation
lab informatics
life sciences
separations
spectroscopy
application notes
industry news

Find Out More

Looking to Buy:

Request info
Request a quote
Request a demo
View this article on its webpage


Login | Register | Advertisers' info | |
Xraycrystallography

Site search

Application notes   Product news   Industry news   Newswire archive

A SelectScience Publication

 Search  

 for  

 

<--ChemBridge Presents Fragment Library for Screening

Find Out More

Looking to Buy:

Request info
Request a quote
Request a demo
View this article on its webpage


ChemBridge’s Fragment Library is an exemplary collection of small molecules useful for fragment-based screening. The emergence and development of high throughput X-ray crystallography and NMR methodologies for drug discovery have contributed widely to the acceptance and implementation of fragment based screening. The ability to detect low affinity binders has proven invaluable in the introduction and promotion of this aspect of drug discovery and design.

The Fragment Library set, comprising approximately 5,000 compounds, was chosen based upon the commonly accepted Astex "Rule-of-Three" (MW <300, H-bond donors/acceptors <3, cLogP <3) as well as the established proprietary ChemBridge substructure filters. The set includes compounds with available, as well as protected, functionality. All compounds in the collection are available in stock and may be cherry-picked or taken as a complete set.

Upon independent analysis of ChemBridge’s Fragment Library, an industry expert from a well respected pharmaceutical company regards the collection as both attractive and diverse.

"The fragment collection has been assembled using industry standard chemometrics coupled with ChemBridge's knowledge of small molecule pharmacophore profiling,” said ChemBridge’s Reg Richardson, Ph.D. “The result is the largest commercial offering of 'discovery chemistry-relevant' small molecule fragments. I am certain the Fragment Library will be valuable to those engaged in fragment based screening to identify and construct new chemical entities having excellent lead-like properties."

back to top »

Related Products

Fragment Library - ChemBridge Corporation

Related Articles

Other SelectScience members who looked at this article were also interested in:

University of Lausanne Uses Syngene's Dyversity To Help Rapidly Identify Proteins Associated with Neurodegenerative Disease - Syngene
TTP LabTech Launches New High-Content Contract Screening Service - TTP LabTech
Esco Announces Launch of New CelCulture® CO2 Incubators - Esco Micro Pte Ltd

 

 

Newswires

Get news like this delivered straight to your inbox with SelectScience newswires:

Supplier details

ChemBridge Corporation
Jennifer Milanovich

USA
T: +1 (858) 451-7400
more details
Send email
Company website
Supplier news archive

More Options

Print
Email

 

 © SelectScience 2010
SelectScience supports The Anaphylaxis Campaign
terms | privacy | links | contact us |  
website by
SelectW3
 

spectroscopynews.net | gcmsnews.net | lcmsnews.net | massspecnews.net | nmrnews.net | ramannews.net | uv-visnews.net | xraycrystallographynews.net | selectsciencenews.net